In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sandoz Pharma Ltd.

Division of Novartis AG

Latest From Sandoz Pharma Ltd.

Weak Q3 For Biocon, All Eyes On Biosimilars Approval Flow

Biocon reported a decline in profits for the third quarter but recent regulatory wins and advancements for its biosimilars portfolio could potentially bring an uptick in growth going forward.

Commercial Companies

Riding The Next Wave Of Biosimilars: Sandoz To Link Up With India's Biocon

Pooling resources appears key to a major new collaboration in the biosimilars space, between Sandoz and India's Biocon, to develop the next generation of biosimilar immunology and oncology products.

Biosimilars Deals

Riding The Next Wave Of Biosimilars: Sandoz To Link Up With India's Biocon

Pooling resources appears key to a major new collaboration in the biosimilars space, between Sandoz and India's Biocon, to develop the next generation of biosimilar immunology and oncology products.

Biosimilars Deals

EU Officials Note Similarities In Post-Approval Changes For Biosimilars, Reference Drugs

EU pharmaceutical and industry officials note some common trends and similarities in post-approval changes for biosimilars and reference products. One vexing problem in instituting post-approval changes is whether to use the reference drug or the approved biosimilar and regulatory guidance in this area is lacking.

Biosimilars Manufacturing
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Switzerland
  • Parent & Subsidiaries
  • Novartis AG
  • Senior Management
  • Daniel Vasella, MD, CEO
    Peter Dufner, Mgr. of Licensing
    Edgar J Fullagar, Head of Mktg.
    Paul L Herrling, PhD, Head of Research
  • Contact Info
  • Sandoz Pharma Ltd.
    Phone: (41) 61 324 7298
    Lichstrasse 35
    Basel, 4002
    Switzerland
Advertisement
Advertisement
UsernamePublicRestriction

Register